70 related articles for article (PubMed ID: 23703635)
1. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition.
Hao H; Chen H; Xie L; Liu H
Ann Med; 2021 Dec; 53(1):1170-1178. PubMed ID: 34259106
[TBL] [Abstract][Full Text] [Related]
3. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.
Ashrafizadeh M; Hushmandi K; Hashemi M; Akbari ME; Kubatka P; Raei M; Koklesova L; Shahinozzaman M; Mohammadinejad R; Najafi M; Sethi G; Kumar AP; Zarrabi A
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784711
[TBL] [Abstract][Full Text] [Related]
5. GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway.
Feng Y; Le F; Tian P; Zhong Y; Zhan F; Huang G; Hu H; Chen T; Tan B
J Cancer; 2021; 12(5):1386-1397. PubMed ID: 33531984
[No Abstract] [Full Text] [Related]
6. Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells.
Zhang N; Hua X; Tu H; Li J; Zhang Z; Max C
Cancer Lett; 2021 Nov; 520():400-408. PubMed ID: 34332039
[TBL] [Abstract][Full Text] [Related]
7. Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder.
Shorning BY; Griffiths D; Clarke AR
PLoS One; 2011 Jan; 6(1):e16209. PubMed ID: 21283818
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of the contribution of ICAM-1 to epithelial-mesenchymal transition (EMT) in bladder cancer.
Zarzycka M; Kotula-Balak M; Gil D
Hum Cell; 2024 May; 37(3):801-816. PubMed ID: 38519725
[TBL] [Abstract][Full Text] [Related]
9. miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers.
Sahib AS; Fawzi A; Zabibah RS; Koka NA; Khudair SA; Muhammad FA; Hamad DA
Cell Signal; 2023 Dec; 112():110881. PubMed ID: 37666286
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan from Sargassum hemiphyllum inhibits the stemness of cancer stem cells and epithelial-mesenchymal transitions in bladder cancer cells.
Sung CJ; Wang HH; Sun KH; Hsieh CC; Huang R; Sun GH; Tang SJ
Int J Biol Macromol; 2022 Nov; 221():623-633. PubMed ID: 36099992
[TBL] [Abstract][Full Text] [Related]
11. ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A.
Wang Y; Wu J; Luo W; Zhang H; Shi G; Shen Y; Zhu Y; Ma C; Dai B; Ye D; Zhu Y
Cell Death Dis; 2021 Jul; 12(7):661. PubMed ID: 34210956
[TBL] [Abstract][Full Text] [Related]
12. Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.
Sun S; Liu J; Zhao M; Han Y; Chen P; Mo Q; Wang B; Chen G; Fang Y; Tian Y; Zhou J; Ma D; Gao Q; Wu P
Cell Death Dis; 2017 Jun; 8(6):e2870. PubMed ID: 28594398
[TBL] [Abstract][Full Text] [Related]
13. Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival.
Pizzo E; Sarcinelli C; Sheng J; Fusco S; Formiggini F; Netti P; Yu W; D'Alessio G; Hu GF
J Cell Sci; 2013 Sep; 126(Pt 18):4308-19. PubMed ID: 23843625
[TBL] [Abstract][Full Text] [Related]
14. New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma.
Zhao W; Liu Y; Yang Y; Wang L
BMC Cancer; 2024 May; 24(1):635. PubMed ID: 38783241
[TBL] [Abstract][Full Text] [Related]
15. Functional status analysis of RNH1 in bladder cancer for predicting immunotherapy response.
Chen S; Ran J; Fan Z; Liu M; Wu L; Li Q; Peng J; Hu Z
Sci Rep; 2023 Aug; 13(1):12625. PubMed ID: 37537337
[TBL] [Abstract][Full Text] [Related]
16. New Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis.
McDonald PC; Dedhar S
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804980
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of miR‑182‑5p on retinal neovascularization by targeting angiogenin and BDNF.
Li C; Lie H; Sun W
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34935052
[TBL] [Abstract][Full Text] [Related]
18. LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion.
Yin Y; Fan Y; Yu G; Du Y
Oncol Lett; 2021 Nov; 22(5):765. PubMed ID: 34589144
[TBL] [Abstract][Full Text] [Related]
19. Angiogenin (ANG)-Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease.
Sarangdhar MA; Allam R
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525475
[TBL] [Abstract][Full Text] [Related]
20. Stress Granules in Cancer.
Song MS; Grabocka E
Rev Physiol Biochem Pharmacol; 2023; 185():25-52. PubMed ID: 32789791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
